Home > FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine

News
FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine

Description

An FDA advisory committee will meet next month to discuss an emergency use authorization. The emergency use authorization would be for Pfizer's COVID-19 vaccine. Earlier this week, Pfizer said clinical trials had shown its vaccine to be 95% effective. "While we cannot predict how long the FDA's review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner," FDA Commissioner Stephen M. Hahn In October, the Emergency Care Research Institute warned against releasing a vaccine. They said six months of follow-up data on clinical trial participants is needed to move forward.

Added on the 21/11/2020 22:08:15 - Copyright : Wochit

To customise your video :

Generic export code

More videos on the subject

Cuomo Thinks Vaccine Will Be Approved Soon

New York Gov. Andrew Cuomo thinks one vaccine could receive FDA emergency authorization. Pfizer and BioNTech's vaccine is the one he was alluding to on Thursday. An independent advisory panel will vote on whether to recommend an emergency use authorization. Several top health officials have said they expect the vaccine to get authorized on Thursday. However, at least one FDA official has said the process could take up to a week after the panel's vote.

10/12/2020 - Wochit
Pfizer's Covid-19 Vaccine Wins Crucial Vote

The covid-19 vaccine developed by Pfizer and BioNTech is one big step closer to the public. A group of outside experts assembled by the FDA largely voted to recommend the vaccine. The vaccine was recommended for emergency use in people ages 16 and older. The over eight-hour advisory committee meeting featured presentations and discussions. However, several members said they were uncomfortable recommending its use to people ages 16-17. The limited data available right now, according to Gizmodo.

11/12/2020 - Wochit
BioNTech And Pfizer To Seek Emergency Authorization For Covid-19 Vaccination

BioNTech and its partner, Pfizer, will seek emergency approval for their Covid-19 vaccine candidate. The drug companies will file paperwork for the emergency use of the vaccine with the US Food and Drug Administration (FDA). In a final analysis of the Phase 3 trial, the vaccine was found to be 95% effective in preventing Covid-19. The vaccine has been shown to work in all age populations. According to CNN, the new vaccine has shown no serious safety concerns. Drug company execs predict distribution to begin before the end of 2020.

19/11/2020 - Wochit
Fauci Revises Estimate Of Vaccination Rate Needed To Achieve Herd Immunity

Dr. Anthony Fauci had previously said it could take up to 90% of the US population to get vaccinated to reach herd immunity against the coronavirus. But on Sunday, he clarified his 'guesstimate' downwards to 70 to 85% of the population. Business Insider reports Fauci admitted on CNN's 'State of the Union' that 'we all have to be honest and humble, nobody really knows for sure.' This month, the US Food and Drug Administration authorized both Moderna and Pfizer and BioNTech's coronavirus vaccine for emergency use. Healthcare professionals and frontline workers across the country have been getting vaccinations since the vaccine rollouts.

28/12/2020 - Wochit
Pfizer Supplying U.S. With 100 Million More COVID Shots

23/12/2020 - Wochit
2ª edición del Festival de Circo Africano de Etiopía

Etiopía

09/03/2018 - Euronews ES